A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
Conditions
Advanced Liver Cancers
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UC Irvine Medical Center, Costa Mesa, California, United States
City of Hope, Duarte, California, United States
UC Irvine Medical Center, Orange, California, United States
University of California San Diego Medical Center, San Diego, California, United States
University of California San Francisco Cancer Center, San Francisco, California, United States
UCLA Center for East, Santa Monica, California, United States
Cherry Creek Medical Center, Aurora, Colorado, United States
University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora, Colorado, United States
UCHealth Cancer Center Pharmacy - Highlands Ranch Hospital, Highlands Ranch, Colorado, United States
Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States
Georgetown University Medical Center, Washington D.C., District of Columbia, United States
University of Kentucky - Markey Cancer Center, Lexington, Kentucky, United States
Oregon Health & Science University, Portland, Oregon, United States
Sarah Cannon Research Institute / Tennessee Oncology, Nashville, Tennessee, United States
Parkland Health & Hospital System, Dallas, Texas, United States
The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
Beijing Cancer Hospital, Beijing, China
Zhongshan Hospital Fudan University, Shanghai, China
Centre Georges Francois Leclerc, Dijon, France
CHU Hôpitaux de Marseille, Marseille, France
Centre Eugène Marquis, Rennes, France
Gustave Roussy, Villejuif, France
Rambam Medical Center, Haifa, Israel
Hadassah University Medical Center, Jerusalem, Israel
Davidof Center - Rabin Medical Center, Petah Tikva, Israel
Sourasky Medical Centre, Tel Aviv, Israel
Auckland City Hospital, Auckland, New Zealand
CHA Bundang Medical Center, Gyeonggi-do, South Korea
Seoul National University Hospital, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
National Cheng Kung University Hospital, Tainan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Study leads
Clinical Trials
Study Director
Hoffmann-La Roche